ATYR

aTyr Pharma
ATYR

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$6.5
507% upside
High target

3 analyst ratings

positive
2  neutral
67%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Wells Fargo
Wells Fargo
Derek Archila
0% 1-yr ATYR win rate
16 Sep ‘25 1 month ago
RBC Capital
RBC Capital
Brian Abrahams
16 Sep ‘25 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Joseph Pantginis
67% 1-yr ATYR win rate
15 Sep ‘25 1 month ago